The University of Southampton
University of Southampton Institutional Repository

Pyridoxal phosphate de-activation by pyrroline-5-carboxylic acid: increased risk of vitamin B6 deficiency and seizures in hyperprolinemia type II

Pyridoxal phosphate de-activation by pyrroline-5-carboxylic acid: increased risk of vitamin B6 deficiency and seizures in hyperprolinemia type II
Pyridoxal phosphate de-activation by pyrroline-5-carboxylic acid: increased risk of vitamin B6 deficiency and seizures in hyperprolinemia type II
We previously identified vitamin B6 deficiency in a child presenting with seizures whose primary diagnosis was the inherited disorder hyperprolinemia type II. This is an unrecognized association, which was not explained by diet or medication. We hypothesized that pyridoxal phosphate (vitamin B6 coenzyme) was de-activated by L-Delta(1)-pyrroline-5-carboxylic acid, the major intermediate that accumulates endogenously in hyperprolinemia type II. The proposed interaction has now been investigated in vitro with high resolution 1H nuclear magnetic resonance spectroscopy and mass spectrometry at a pH of 7.4 and temperature of 310 K. Three novel adducts were identified. These were the result of a Claisen condensation (or Knoevenagel type of reaction) of the activated C-4 carbon of the pyrroline ring with the aldehyde carbon of pyridoxal phosphate. The structures of the adducts were confirmed by a combination of high performance liquid chromatography, nuclear magnetic resonance, and mass spectrometry. This interaction has not been reported before. From preliminary observations, pyrroline-5-carboxylic acid also condenses with other aromatic and aliphatic aldehydes and ketones, and this may be a previously unsuspected generic addition reaction. Pyrroline-5-carboxylic acid is thus found to be a unique endogenous vitamin antagonist. Vitamin B6 de-activation may contribute to seizures in hyperprolinemia type II, which are so far unexplained, but they may be preventable with long term vitamin B6 supplementation.
5-carboxylate dehydrogenase, pyrroline 5-carboxylate, rat-liver, metabolism, identification, spectroscopy, purification, diffusion, plasma
0021-9258
15107-15116
Farrant, R.D.
f6c40b78-5159-4fc6-ac57-fce52e219608
Walker, V.
60118e30-565e-42c4-8d7d-ab1c39c1436c
Mills, G.A.
841f321a-5d31-4381-b87a-418614d03d4a
Mellor, J.M.
748aff30-b9fb-420a-8c4b-8b95beb6ecd0
Langley, G.J.
7ac80d61-b91d-4261-ad17-255f94ea21ea
Farrant, R.D.
f6c40b78-5159-4fc6-ac57-fce52e219608
Walker, V.
60118e30-565e-42c4-8d7d-ab1c39c1436c
Mills, G.A.
841f321a-5d31-4381-b87a-418614d03d4a
Mellor, J.M.
748aff30-b9fb-420a-8c4b-8b95beb6ecd0
Langley, G.J.
7ac80d61-b91d-4261-ad17-255f94ea21ea

Farrant, R.D., Walker, V., Mills, G.A., Mellor, J.M. and Langley, G.J. (2001) Pyridoxal phosphate de-activation by pyrroline-5-carboxylic acid: increased risk of vitamin B6 deficiency and seizures in hyperprolinemia type II. The Journal of Biological Chemistry, 276 (18), 15107-15116. (doi:10.1074/jbc.M010860200).

Record type: Article

Abstract

We previously identified vitamin B6 deficiency in a child presenting with seizures whose primary diagnosis was the inherited disorder hyperprolinemia type II. This is an unrecognized association, which was not explained by diet or medication. We hypothesized that pyridoxal phosphate (vitamin B6 coenzyme) was de-activated by L-Delta(1)-pyrroline-5-carboxylic acid, the major intermediate that accumulates endogenously in hyperprolinemia type II. The proposed interaction has now been investigated in vitro with high resolution 1H nuclear magnetic resonance spectroscopy and mass spectrometry at a pH of 7.4 and temperature of 310 K. Three novel adducts were identified. These were the result of a Claisen condensation (or Knoevenagel type of reaction) of the activated C-4 carbon of the pyrroline ring with the aldehyde carbon of pyridoxal phosphate. The structures of the adducts were confirmed by a combination of high performance liquid chromatography, nuclear magnetic resonance, and mass spectrometry. This interaction has not been reported before. From preliminary observations, pyrroline-5-carboxylic acid also condenses with other aromatic and aliphatic aldehydes and ketones, and this may be a previously unsuspected generic addition reaction. Pyrroline-5-carboxylic acid is thus found to be a unique endogenous vitamin antagonist. Vitamin B6 de-activation may contribute to seizures in hyperprolinemia type II, which are so far unexplained, but they may be preventable with long term vitamin B6 supplementation.

This record has no associated files available for download.

More information

Published date: 2001
Keywords: 5-carboxylate dehydrogenase, pyrroline 5-carboxylate, rat-liver, metabolism, identification, spectroscopy, purification, diffusion, plasma

Identifiers

Local EPrints ID: 19474
URI: http://eprints.soton.ac.uk/id/eprint/19474
ISSN: 0021-9258
PURE UUID: 27ef4b5e-685f-4bef-9cd4-8479d6cb4ab9
ORCID for G.J. Langley: ORCID iD orcid.org/0000-0002-8323-7235

Catalogue record

Date deposited: 15 Feb 2006
Last modified: 16 Mar 2024 02:41

Export record

Altmetrics

Contributors

Author: R.D. Farrant
Author: V. Walker
Author: G.A. Mills
Author: J.M. Mellor
Author: G.J. Langley ORCID iD

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×